On the other hand, POLE2 had been previously reported to be highly expressed in breast cancer, colorectal cancer, cervical cancer and bladder cancer (Zhou et al., 2008; Liu et al., 2014; Chubb et al., 2016). Here, POLE2 is linked to breast carcinoma.